These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15529177)

  • 1. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
    Son SH; Yu E; Choi EK; Lee H; Choi J
    Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis.
    Le XF; Vallian S; Mu ZM; Hung MC; Chang KS
    Oncogene; 1998 Apr; 16(14):1839-49. PubMed ID: 9583681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid attenuates promyelocytic leukemia protein-induced cell death in breast cancer cells by activation of the ubiquitin-proteasome pathway.
    Son SH; Yu E; Ahn Y; Choi EK; Lee H; Choi J
    Cancer Lett; 2007 Mar; 247(2):213-23. PubMed ID: 16740359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells.
    Vannucchi S; Percario ZA; Chiantore MV; Matarrese P; Chelbi-Alix MK; Fagioli M; Pelicci PG; Malorni W; Fiorucci G; Romeo G; Affabris E
    Oncogene; 2000 Oct; 19(44):5041-53. PubMed ID: 11042692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.
    Lin L; Ozaki T; Takada Y; Kageyama H; Nakamura Y; Hata A; Zhang JH; Simonds WF; Nakagawara A; Koseki H
    Oncogene; 2005 May; 24(21):3385-96. PubMed ID: 15735665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The molecular mechanism of PML in inducing apoptosis of bladder cancer cell line].
    Li L; He DL; He H; Wang XY; Zhang LL; Luo Y; Nan XY
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1766-9. PubMed ID: 16253165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.
    Mologni L; Marchesi E; Nielsen PE; Gambacorti-Passerini C
    Cancer Res; 2001 Jul; 61(14):5468-73. PubMed ID: 11454693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of PML induced apoptosis in bladder cancer cell by caspase dependent pathway.
    Li L; He D; He H; Wang X; Zhang L; Luo Y; Nan X
    Cancer Lett; 2006 May; 236(2):259-68. PubMed ID: 16216409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E1A-mediated suppression of EGFR expression and induction of apoptosis in head and neck squamous carcinoma cell lines.
    Flinterman M; Gäken J; Farzaneh F; Tavassoli M
    Oncogene; 2003 Apr; 22(13):1965-77. PubMed ID: 12673202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells.
    He D; Mu ZM; Le X; Hsieh JT; Pong RC; Chung LW; Chang KS
    Cancer Res; 1997 May; 57(10):1868-72. PubMed ID: 9157977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
    Komura N; Asakawa M; Umezawa K; Segawa K
    Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
    Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
    Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
    Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
    Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the promyelocytic leukemia gene suppresses growth of human bladder cancer cells by inducing G1 cell cycle arrest and apoptosis.
    He D; Nan X; Chang KS; Wang Y; Chung LW
    Chin Med J (Engl); 2003 Sep; 116(9):1394-8. PubMed ID: 14527374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies.
    Katano H; Ogawa-Goto K; Hasegawa H; Kurata T; Sata T
    Virology; 2001 Aug; 286(2):446-55. PubMed ID: 11485412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
    Duprez E; Lillehaug JR; Naoe T; Lanotte M
    Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.